Overview

A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2000-10-01
Target enrollment:
Participant gender:
Summary
To compare acetaminophen (Tylenol) with rofecoxib (Viox) for the treatment of Osteoarthritis of the Knee
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Consumer and Personal Products Worldwide
Treatments:
Acetaminophen
Rofecoxib